Rave drug holds promise for treating depression fast

Sara Reardon

Nature, 2015, vol. 517, issue 7533, 130-131

Abstract: Companies and clinicians turn to ketamine to treat mental-health disorder as pipeline of new drugs dries up.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/517130a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:517:y:2015:i:7533:d:10.1038_517130a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/517130a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().